NO156787B - Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.

Info

Publication number
NO156787B
NO156787B NO800881A NO800881A NO156787B NO 156787 B NO156787 B NO 156787B NO 800881 A NO800881 A NO 800881A NO 800881 A NO800881 A NO 800881A NO 156787 B NO156787 B NO 156787B
Authority
NO
Norway
Prior art keywords
preparation
rog
rer
hydrogen
quinolo
Prior art date
Application number
NO800881A
Other languages
English (en)
Other versions
NO156787C (no
NO800881L (no
Inventor
Roy Victor Davies
James Fraser
Kenneth John Nichol
Raymond Parkinson
David Bryan Yates
Malcolm Freeman Sim
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO800881L publication Critical patent/NO800881L/no
Publication of NO156787B publication Critical patent/NO156787B/no
Publication of NO156787C publication Critical patent/NO156787C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Nye 4-kinolon-forbindelser med antihypertensiv aktivitet og med den generelle formel:. hvor n er 0, 1 eller 2; Rer lavere alkyl eventuelt substituert med hydroksy eller C_-alkoksykarbonyl; allyl; propynyl eller fenyl- lavere alkyl hvori fenylringen eventuelt er substituert med 1 eller 2 C_-alkoksygrupper; R.2 er C_alkyl; og < Rog R, som kan være like eller forskjellige, er hydrogen, lavere alkyl, lavere alkoksy, lavere alkanoyl, halogen, trifluormetyl eller lavere alkyltio med den betingelse at (a) når R, Rog R^ er hydrogen og Rer metyl, inneholder Rmer enn ett karbonatom, og (b) når Rog Rer hydrogen, Rer hydrogen eller 7-metyl og Rer etyl, inneholder mer enn ett karbonatom.Fremstilling av forbindelsene er beskrevet.
NO800881A 1979-03-27 1980-03-26 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. NO156787C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7910558 1979-03-27
GB7939505 1979-11-15

Publications (3)

Publication Number Publication Date
NO800881L NO800881L (no) 1980-09-29
NO156787B true NO156787B (no) 1987-08-17
NO156787C NO156787C (no) 1987-11-25

Family

ID=26271029

Family Applications (1)

Application Number Title Priority Date Filing Date
NO800881A NO156787C (no) 1979-03-27 1980-03-26 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.

Country Status (34)

Country Link
US (1) US4302460A (no)
KR (1) KR840001612B1 (no)
AT (1) AT379390B (no)
AU (1) AU536616B2 (no)
BG (2) BG37993A3 (no)
CA (1) CA1151652A (no)
CH (1) CH644366A5 (no)
CS (1) CS221906B2 (no)
DD (1) DD149608A5 (no)
DE (2) DE3011994A1 (no)
DK (1) DK151252C (no)
EG (1) EG16606A (no)
FI (1) FI77026C (no)
FR (2) FR2452484A1 (no)
GR (1) GR68007B (no)
HK (1) HK94986A (no)
HU (1) HU179845B (no)
IE (1) IE49562B1 (no)
IL (1) IL59710A (no)
IT (1) IT1188916B (no)
KE (1) KE3649D (no)
LU (1) LU82295A1 (no)
MX (1) MX6816E (no)
MY (1) MY8600668A (no)
NL (1) NL191306C (no)
NO (1) NO156787C (no)
NZ (1) NZ193167A (no)
PH (1) PH16758A (no)
PL (1) PL124037B1 (no)
PT (1) PT71006A (no)
RO (1) RO79397A (no)
SE (1) SE455422B (no)
SG (1) SG60886G (no)
YU (1) YU42332B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
US4552884A (en) * 1984-01-13 1985-11-12 The Boots Company Plc Method of treating heart disease
EP0172004B1 (en) * 1984-08-15 1990-03-21 The Boots Company PLC Quinolinones, process for their preparation and pharmaceutical compositions containing them
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
GB8918952D0 (en) * 1989-08-19 1989-10-04 Boots Co Plc Therapeutic agents
FR2672597B1 (fr) * 1991-02-07 1995-05-19 Roussel Uclaf Nouveaux derives n-substitues de la quinoleine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
IL100555A (en) * 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
FR2684671B1 (fr) * 1991-11-20 1995-05-19 Roussel Uclaf Nouveaux derives de la quinoleine, leur procede de preparation et intermediaires et leur application a titre de medicaments.
FR2680511B1 (fr) * 1991-08-20 1995-05-19 Roussel Uclaf Derives n-substitues de la quinoleine, leur procede de preparation, intermediaires obtenus, leur application comme medicaments et les compositions les renfermant.
JP2002522388A (ja) * 1998-08-03 2002-07-23 ビーエーエスエフ コーポレーション 性機能障害の治療のためのピリジノン
US6307050B1 (en) * 2000-08-29 2001-10-23 R. T. Alamo Venture I Llc Method of synthesizing flosequinan from 4-fluoroanthranilic acid
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6562838B2 (en) 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6649764B2 (en) * 2001-10-25 2003-11-18 R. T. Alamo Ventures I, Llc Stereospecific enrichment of heterocyclic enantiomers
US6730790B2 (en) * 2002-03-01 2004-05-04 R.T. Alamo Ventures I. Llc Chlorinated heterocyclic compounds and methods of synthesis

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178348A (en) * 1961-02-08 1965-04-13 Norwich Pharma Co Hypotensive quinolines
GB1066919A (en) 1964-04-03 1967-04-26 Hoffmann La Roche Novel benzyl amine derivatives
DE1770482A1 (de) * 1968-05-22 1971-11-11 Basf Ag Verfahren zur Herstellung von 2,4-Dioxychinolinen
US3798219A (en) * 1971-10-18 1974-03-19 Warner Lambert Co 3-(methylsulfinyl)cinnolinones and their derivatives
US3772301A (en) * 1971-11-22 1973-11-13 Warner Lambert Co (4-substituted)4-(methylsulfinyl)methylcarbostyrils
CH607848A5 (no) * 1974-06-04 1978-11-30 Bayer Ag
GB1488411A (en) * 1975-01-16 1977-10-12 Wyeth John & Brother Ltd 3,4-dihydro-4-arylquinolin-4-ol derivatives
US4124587A (en) * 1976-03-01 1978-11-07 Sandoz, Inc. 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones
US4127574A (en) * 1976-03-01 1978-11-28 Sandoz, Inc. 4-Hydroxy-3-sulfonyl-quinolin-2(1H)-ones
DE2616995A1 (de) 1976-04-17 1977-10-27 Bayer Ag 1.4-dihydropyridine mit schwefelhaltigen substituenten mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2616991A1 (de) 1976-04-17 1977-10-27 Bayer Ag Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2639257A1 (de) 1976-09-01 1978-03-02 Bayer Ag Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2639498A1 (de) 1976-09-02 1978-03-09 Bayer Ag Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2641746C2 (de) 1976-09-16 1986-11-06 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-Zuckerderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2658183A1 (de) 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658804A1 (de) 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel
DE2715182A1 (de) 1977-04-05 1978-10-19 Bayer Ag 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4177278A (en) * 1977-04-05 1979-12-04 Bayer Aktiengesellschaft 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use
JPS5424882A (en) * 1977-07-22 1979-02-24 Yamanouchi Pharmaceut Co Ltd Novel heterocyclic compounds and their preparation
DE2747513A1 (de) 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen

Also Published As

Publication number Publication date
FI77026B (fi) 1988-09-30
FR2452484B1 (no) 1983-08-12
FI800923A (fi) 1980-09-28
FR2468367A1 (fr) 1981-05-08
FR2468367B1 (no) 1983-09-30
HU179845B (en) 1982-12-28
KR830001898A (ko) 1983-05-19
AU5670280A (en) 1980-10-02
DK151252B (da) 1987-11-16
DD149608A5 (de) 1981-07-22
DK151252C (da) 1988-05-16
KE3649D (en) 1986-08-01
YU42332B (en) 1988-08-31
MX6816E (es) 1986-08-05
PL124037B1 (en) 1982-12-31
PH16758A (en) 1984-02-15
IT8048262A0 (it) 1980-03-26
IE49562B1 (en) 1985-10-30
NL8001771A (nl) 1980-09-30
LU82295A1 (fr) 1981-04-17
YU84980A (en) 1983-09-30
SG60886G (en) 1987-03-27
DE3051205C2 (de) 1991-01-24
NO156787C (no) 1987-11-25
FI77026C (fi) 1989-01-10
DK130180A (da) 1980-09-28
CA1151652A (en) 1983-08-09
NZ193167A (en) 1984-08-24
NO800881L (no) 1980-09-29
US4302460A (en) 1981-11-24
HK94986A (en) 1986-12-12
IL59710A (en) 1984-01-31
BG37836A3 (en) 1985-08-15
IT1188916B (it) 1988-01-28
DE3011994A1 (de) 1980-10-16
NL191306C (nl) 1995-05-16
NL191306B (nl) 1994-12-16
GR68007B (no) 1981-10-26
BG37993A3 (en) 1985-09-16
AT379390B (de) 1985-12-27
DE3011994C2 (no) 1991-06-27
SE8002345L (sv) 1980-11-14
IT8048262A1 (it) 1981-09-26
AU536616B2 (en) 1984-05-17
IE800567L (en) 1980-09-27
KR840001612B1 (ko) 1984-10-11
EG16606A (en) 1989-01-30
PL223050A1 (no) 1981-01-30
RO79397A (ro) 1982-06-25
CH644366A5 (fr) 1984-07-31
FR2452484A1 (fr) 1980-10-24
PT71006A (en) 1980-04-01
SE455422B (sv) 1988-07-11
MY8600668A (en) 1986-12-31
ATA161880A (de) 1985-05-15
CS221906B2 (en) 1983-04-29

Similar Documents

Publication Publication Date Title
NO156787B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
MY131297A (en) Herbicides
WO2002008219A3 (en) 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
ES8406440A1 (es) Procedimiento para preparar derivados de 2-amino-3-acilamino-6-bencilamino-piridina
MY117783A (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
ZA823414B (en) Anti-hypertensive 1-substituted spiro (piperidine-oxobenzoxazine)s
IL106395A (en) 4-benzoylisoxazole derivatives, process for their preparation and herbicidal compositions containing them
NO168246C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
IE802684L (en) Quinoline derivatives
ES8506594A1 (es) Un procedimiento para obtener derivados de indanilbenzamida
ES8201947A1 (es) Un procedimiento para preparar 9-aminoalquilfluorenos
ES446993A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzofenona.
ES8202818A1 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
JPS5430184A (en) 3,4-dihydrocarbostyril derivative
ES8304956A1 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
JPS5432468A (en) Pyrrole derivatives
IE780426L (en) Oxadiazole derivatives
JPS5246095A (en) Preparation of novel thienopyrimidine derivatives
ES8705379A1 (es) Procedimiento para la obtencion de derivados de benzaldoxim-carbamato
IE56365B1 (en) Treatment of migraine with n-alkyl-piperidinyl benzoate derivatives
IE41549L (en) N-sulphenylated arylcarbamates
ES8801542A1 (es) Procedimiento para preparar compuestos arilsulfonicos.
DE3060314D1 (en) Heterocyclic spiro-amidines, their stereoisomers and optical isomers, methods for their preparation and medicaments containing them
JPS5427567A (en) 4-(indoline-2, 2-(2h)-yl) methyl-7-substituted aminospiro (indoline-2,2-(2h)-1-benzopyran) derivatives
JPS5430191A (en) 2-(1-piperazinylmethyl)-5-phenyloxazoles and their pharmaceutically permissi ble acid addition salt